Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,551–5,575 of 7,816 matching trials · page 223 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Validation of the German Version of the Amsterdam Instrumental Activities of Daily Living Questionnaire® NCT04012398 Amsterdam IADL Questionnaire short, German version Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 96 | Zurich University of Applied Sciences OTHER |
2019-10-30 |
|
Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease NCT01832350 Nuedexta (20/10) Runs in: United States · 1 site |
PHASE4 other |
TERMINATED | 34 | St. Joseph's Hospital and Medical Center, Phoenix OTHER |
2019-10-29 |
|
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases NCT02084147 positron emission tomography; computed tomography; magnetic resonan... Runs in: United States · 1 site |
NA other |
COMPLETED | 72 | Case Comprehensive Cancer Center OTHER |
2019-10-29 |
|
Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD) NCT02759887 biospecimen collection; cognitive assessments; caregiver questionna... Runs in: United States · 1 site |
NA other |
COMPLETED | 19 | St. Joseph's Hospital and Medical Center, Phoenix OTHER |
2019-10-29 |
|
FuRST 2.0 Cognitive Pre-testing - Round 2 NCT03709173 FuRST 2.0 Runs in: Canada; United States · 4 sites |
NA other |
COMPLETED | 52 | CHDI Foundation, Inc. OTHER |
2019-10-29 |
|
Modafinil Treatment for Sleep/Wake Disturbances in Older Adults NCT00626210 modafinil Runs in: United States · 1 site |
PHASE4 other |
TERMINATED | 2 | VA Palo Alto Health Care System OTHER_GOV |
2019-10-28 |
|
Hand Grasping Techniques on Eliciting the Grasp Reflex in Patients With Dementia NCT02925273 palmar grasp without dorsal stimulation; standard palmar grasp test... Runs in: United States · 1 site |
NA other |
COMPLETED | 1 | Rowan University OTHER |
2019-10-28 |
|
Evaluation of Safety and Tolerability of Libella Gene Therapy for Alzheimer's Disease: AAV- hTERT NCT04133454 AAV-hTERT Runs in: Colombia · 1 site |
PHASE1 gene-therapy |
UNKNOWN | 5 | Libella Gene Therapeutics INDUSTRY |
2019-10-28 |
|
Processing of Music in Alzheimer Patients NCT04132193 |
NA other |
UNKNOWN | 50 | Turku University Hospital OTHER_GOV |
2019-10-25 |
|
DC Longitudinal Study on Aging and Specimen Bank NCT03702907 Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000 | Georgetown University OTHER |
2019-10-24 |
|
Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-stroke NCT04135872 strengthened nuitritional treatment Runs in: China · 1 site |
NA other |
COMPLETED | 435 | Dongguan People's Hospital OTHER_GOV |
2019-10-24 |
|
Educational Video to Improve Nursing Home Care in End-stage Dementia NCT01774799 Advance care planning intervention; Control group Runs in: United States · 1 site |
NA other |
COMPLETED | 804 | Hebrew SeniorLife OTHER |
2019-10-23 |
|
Blood Biomarker of Alzheimer's Disease (AD) NCT03340571 Runs in: United States · 1 site |
NA other |
COMPLETED | 21 | Duke University OTHER |
2019-10-23 |
|
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 NCT03802162 CKD-355A (D797/Memantine HCl 20mg); CKD-355B (D797/Memantine HCl 20... Runs in: South Korea · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 60 | Chong Kun Dang Pharmaceutical INDUSTRY |
2019-10-23 |
|
Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease NCT03283059 Octohydroaminoacridine Succinate; Aricept; Placebos Runs in: China · 1 site |
PHASE3 other |
UNKNOWN | 600 | Shanghai Mental Health Center OTHER |
2019-10-22 |
|
ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease NCT00934050 ELND005 (scyllo-inositol) Runs in: Canada; United States · 38 sites |
PHASE2 anti-amyloid-aggregation |
COMPLETED | 103 | OPKO Health, Inc. INDUSTRY |
2019-10-21 |
|
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease NCT01735630 ELND005; Placebo Runs in: Canada; Spain; United Kingdom; United States · 70 sites |
PHASE2 anti-amyloid-aggregation |
COMPLETED | 350 | OPKO Health, Inc. INDUSTRY |
2019-10-21 |
|
A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease NCT01766336 Group 1 ELND005; Group 2 ELND005 Runs in: Canada; Spain; United Kingdom; United States · 46 sites |
PHASE2 anti-amyloid-aggregation |
TERMINATED | 296 | OPKO Health, Inc. INDUSTRY |
2019-10-21 |
|
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies NCT03052712 social cognition Runs in: France · 1 site |
NA other |
TERMINATED | 44 | Centre Hospitalier Universitaire, Amiens OTHER |
2019-10-21 |
|
Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera NCT03438123 CZT SPECT imaging Runs in: France · 1 site |
NA other |
COMPLETED | 140 | Spectrum Dynamics INDUSTRY |
2019-10-21 |
|
18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls NCT03625128 F-18 Runs in: Taiwan · 1 site |
EARLY_PHASE1 other |
COMPLETED | 36 | Chang Gung Memorial Hospital OTHER |
2019-10-21 |
|
Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061) NCT02750306 Suvorexant; Placebo |
PHASE3 other |
COMPLETED | 285 | Merck Sharp & Dohme LLC INDUSTRY |
2019-10-16 |
|
Brain Aging and Treatment Response in Geriatric Depression NCT01902004 Escitalopram; Memantine; Placebo Runs in: United States · 1 site |
PHASE4 symptomatic-cholinergic |
COMPLETED | 115 | University of California, Los Angeles OTHER |
2019-10-15 |
|
Exergaming Versus Aerobic Exercises on Mild Cognitive Impairment NCT04127448 Exergaming Training Group; Aerobic Exercise Group Runs in: Pakistan · 1 site |
NA other |
COMPLETED | 33 | Riphah International University OTHER |
2019-10-15 |
|
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease NCT02760602 Solanezumab; Placebo Runs in: Canada; Finland; France; Germany; Italy; Japan; Poland; P... · 193 sites |
PHASE3 anti-amyloid-antibody |
TERMINATED | 26 | Eli Lilly and Company INDUSTRY |
2019-10-10 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial